|
1
|
Woods WG: Curing childhood acute myeloid
leukemia (AML) at the half-way point: promises to keep and miles to
go before we sleep. Pediatr Blood Cancer. 46:565–569. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gorman MF, Ji L, Ko RH, et al: Outcome for
children treated for relapsed or refractory acute myelogenous
leukemia (rAML): a Therapeutic Advances in Childhood Leukemia
(TACL) Consortium study. Pediatr Blood Cancer. 55:421–429. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kaspers GJ and Zwaan CM: Pediatric acute
myeloid leukemia: towards high-quality cure of all patients.
Haematologica. 92:1519–1532. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Benchaouir R, Rameau P, Decraene C, et al:
Evidence for a resident subset of cells with SP phenotype in the
C2C12 myogenic line: a tool to explore muscle stem cell biology.
Exp Cell Res. 294:254–268. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schatton T, Murphy GF, Frank NY, et al:
Identification of cells initiating human melanomas. Nature.
451:345–349. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lapidot T, Sirard C, Vormoor J, et al: A
cell initiating human acute myeloid leukaemia after transplantation
into SCID mice. Nature. 367:645–648. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kondo T, Setoguchi T and Taga T:
Persistence of a small subpopulation of cancer stem-like cells in
the C6 glioma cell line. Proc Natl Acad Sci USA. 101:781–786. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hirschmann-Jax C, Foster AE, Wulf GG, et
al: A distinct ‘side population’ of cells with high drug efflux
capacity in human tumor cells. Proc Natl Acad Sci USA.
101:14228–14233. 2004.
|
|
12
|
Goodell MA, Brose K, Paradis G, Conner AS
and Mulligan RC: Isolation and functional properties of murine
hematopoietic stem cells that are replicating in vivo. J Exp Med.
183:1797–1806. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shimano K, Satake M, Okaya A, et al:
Hepatic oval cells have the side population phenotype defined by
expression of ATP-binding cassette transporter ABCG2/BCRP1. Am J
Pathol. 163:3–9. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Falciatori I, Borsellino G, Haliassos N,
et al: Identification and enrichment of spermatogonial stem cells
displaying side-population phenotype in immature mouse testis.
FASEB J. 18:376–378. 2004.PubMed/NCBI
|
|
15
|
Hu C, Li H, Li J, et al: Analysis of ABCG2
expression and side population identifies intrinsic drug efflux in
the HCC cell line MHCC-97L and its modulation by Akt signaling.
Carcinogenesis. 29:2289–2297. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang J, Guo LP, Chen LZ, Zeng YX and Lu
SH: Identification of cancer stem cell-like side population cells
in human nasopharyngeal carcinoma cell line. Cancer Res.
67:3716–3724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Haraguchi N, Utsunomiya T, Inoue H, et al:
Characterization of a side population of cancer cells from human
gastrointestinal system. Stem Cells. 24:506–513. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Setoguchi T, Taga T and Kondo T: Cancer
stem cells persist in many cancer cell lines. Cell Cycle.
3:414–415. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Feuring-Buske M and Hogge DE: Hoechst
33342 efflux identifies a subpopulation of cytogenetically normal
CD34(+)CD38(−) progenitor cells from patients with acute myeloid
leukemia. Blood. 97:3882–3889. 2001.PubMed/NCBI
|
|
20
|
Guo Y, Follo M, Geiger K, Lubbert M and
Engelhardt M: Side-population cells from different precursor
compartments. J Hematother Stem Cell Res. 12:71–82. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tsuchiya S, Yamabe M, Yamaguchi Y,
Kobayashi Y, Konno T and Tada K: Establishment and characterization
of a human acute monocytic leukemia cell line (THP-1). Int J
Cancer. 26:171–176. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao Q, Geng L, Kvalheim G, Gaudernack G
and Suo Z: Identification of cancer stem-like side population cells
in ovarian cancer cell line OVCAR-3. Ultrastruct Pathol.
33:175–181. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ishikawa T and Nakagawa H: Human ABC
transporter ABCG2 in cancer chemotherapy and pharmacogenomics. J
Exp Ther Oncol. 8:5–24. 2009.PubMed/NCBI
|
|
24
|
Rombouts WJ, Martens AC and Ploemacher RE:
Identification of variables determining the engraftment potential
of human acute myeloid leukemia in the immunodeficient NOD/SCID
human chimera model. Leukemia. 14:889–897. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jonker JW, Freeman J, Bolscher E, et al:
Contribution of the ABC transporters Bcrp1 and Mdr1a/1b to the side
population phenotype in mammary gland and bone marrow of mice. Stem
Cells. 23:1059–1065. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Raguz S and Yague E: Resistance to
chemotherapy: new treatments and novel insights into an old
problem. Br J Cancer. 99:387–391. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zheng X, Seshire A, Ruster B, et al:
Arsenic but not all-trans retinoic acid overcomes the aberrant stem
cell capacity of PML/RARalpha-positive leukemic stem cells.
Haematologica. 92:323–331. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matsui W, Wang Q, Barber JP, et al:
Clonogenic multiple myeloma progenitors, stem cell properties, and
drug resistance. Cancer Res. 68:190–197. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kayo H, Yamazaki H, Nishida H, Dang NH and
Morimoto C: Stem cell properties and the side population cells as a
target for interferon-α in adult T-cell leukemia/lymphoma. Biochem
Biophys Res Commun. 364:808–814. 2007.PubMed/NCBI
|
|
30
|
Wang JC and Dick JE: Cancer stem cells:
lessons from leukemia. Trends Cell Biol. 15:494–501. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Blair A, Hogge DE, Ailles LE, Lansdorp PM
and Sutherland HJ: Lack of expression of Thy-1 (CD90) on acute
myeloid leukemia cells with long-term proliferative ability in
vitro and in vivo. Blood. 89:3104–3112. 1997.PubMed/NCBI
|
|
32
|
Blair A and Sutherland HJ: Primitive acute
myeloid leukemia cells with long-term proliferative ability in
vitro and in vivo lack surface expression of c-kit (CD117). Exp
Hematol. 28:660–671. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Naka K, Hoshii T and Hirao A: Novel
therapeutic approach to eradicate tyrosine kinase inhibitor
resistant chronic myeloid leukemia stem cells. Cancer Sci.
101:1577–1581. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hope KJ, Jin L and Dick JE: Acute myeloid
leukemia originates from a hierarchy of leukemic stem cell classes
that differ in self-renewal capacity. Nat Immunol. 5:738–743. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Clarke RB: Isolation and characterization
of human mammary stem cells. Cell Prolif. 38:375–386. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chang XB: Molecular mechanism of
ATP-dependent solute transport by multidrug resistance-associated
protein 1. Methods Mol Biol. 596:223–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou S, Schuetz JD, Bunting KD, et al: The
ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem
cells and is a molecular determinant of the side-population
phenotype. Nat Med. 7:1028–1034. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Doyle LA and Ross DD: Multidrug resistance
mediated by the breast cancer resistance protein BCRP (ABCG2).
Oncogene. 22:7340–7358. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Summer R, Kotton DN, Sun X, Ma B,
Fitzsimmons K and Fine A: Side population cells and Bcrp1
expression in lung. Am J Physiol Lung Cell Mol Physiol.
285:L97–L104. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bunting KD, Zhou S, Lu T and Sorrentino
BP: Enforced P-glycoprotein pump function in murine bone marrow
cells results in expansion of side population stem cells in vitro
and repopulating cells in vivo. Blood. 96:902–909. 2000.PubMed/NCBI
|
|
41
|
Taipale J and Beachy PA: The Hedgehog and
Wnt signalling pathways in cancer. Nature. 411:349–354. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
van Stijn A, van der Pol MA, Kok A, et al:
Differences between the CD34+ and CD34− blast
compartments in apoptosis resistance in acute myeloid leukemia.
Haematologica. 88:497–508. 2003.
|
|
43
|
Chipuk JE, Moldoveanu T, Llambi F, Parsons
MJ and Green DR: The BCL-2 family reunion. Mol Cell. 37:299–310.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang QL, Niu Q, Niu PY, et al: Bax gene
silencing: a potential intervention in aluminum-induced neural cell
death. J Biol Regul Homeost Agents. 24:7–17. 2010.PubMed/NCBI
|
|
45
|
Komuro H, Saihara R, Shinya M, et al:
Identification of side population cells (stem-like cell population)
in pediatric solid tumor cell lines. J Pediatr Surg. 42:2040–2045.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Misaghian N, Ligresti G, Steelman LS, et
al: Targeting the leukemic stem cell: the Holy Grail of leukemia
therapy. Leukemia. 23:25–42. 2009. View Article : Google Scholar : PubMed/NCBI
|
